IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD27) (HUMAN MONOCLONAL CDX-1127 CLONE 1F5 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CDX-1127 CLONE 1F5 .KAPPA.-CHAIN, DIMER
Glioma, Astrocytic
Nicholas Butowskimonoclonal_antibodyPhase 1Dormant
C
38/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 23/ 100
- Competitive Position
- 95/ 100
Competitive context
16 Active assets in the Glioma, Astrocytic cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Carboplatin Oliver Jonas | Phase 2 | BB |
Irinotecan Julie Krystal | Phase 2 | BB |
(+)-VINCRISTINE Novartis Pharmaceuticals | Phase 2 | BB |
gsk1120212 Novartis Pharmaceuticals | Phase 4 | BB |
Dabrafenib Novartis Pharmaceuticals | Phase 4 | BB |
View all 40 →
Same molecule, other indications
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD27) (HUMAN MONOCLONAL CDX-1127 CLONE 1F5 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CDX-1127 CLONE 1F5 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →